ZHEJIANG ZHENYUAN(SZ:000705) Zhong Guo Jing Ji Wang·2025-10-22 06:49Core Viewpoint - Zhejiang Zhenyuan has decided to terminate its plan to issue shares to specific investors and has withdrawn its application due to considerations of the current capital market environment and the company's overall development strategy [1][2]. Group 1: Termination of Share Issuance - The company held a board meeting on October 21, 2025, where it approved the decision to terminate the share issuance and withdraw the application [1]. - The termination decision was made after thorough communication and analysis with relevant parties, considering the current capital market conditions [2]. Group 2: Financial Implications - The company stated that the termination of the share issuance will not adversely affect its normal production and operations, nor will it harm the interests of shareholders, especially minority shareholders [2]. - The planned fundraising amount was up to 49,500 million CNY, intended for specific projects including the construction of a production base for various biochemical products and an enhancement project for raw materials [2][3]. Group 3: Project Details - The projects intended for the raised funds included: 1. Construction of a production base for 2,400 tons of histidine, 1,000 tons of levodopa, and 1,000 tons of tyrosine, with a total investment of approximately 58.70 million CNY and planned fundraising of 30 million CNY [3]. 2. A project for enhancing raw material production with a total investment of about 48.12 million CNY and planned fundraising of 19.50 million CNY [3]. - The total investment for both projects was approximately 106.83 million CNY, with a total planned fundraising of 49.50 million CNY [3].